Immune attack: the role of inflammation in Alzheimer disease. (Q38492631)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25991443%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

Immune attack: the role of inflammation in Alzheimer disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25991443%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

0 references

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25991443%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25991443%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Richard M Ransohoff

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25991443%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

language of work or name

English

0 references

publication date

1 June 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25991443%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Neuroscience

8 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25991443%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25991443%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25991443%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

358-372

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25991443%20AND%20SRC:MED&resulttype=core&format=json

Macrophage activation and polarization: nomenclature and experimental guidelines

8 March 2020

cites work

1 reference

31 March 2020

1 reference

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

31 March 2020

1 reference

Microglia actions in Alzheimer’s disease.

31 March 2020

1 reference

Microglia as dynamic and essential components of the amyloid hypothesis

31 March 2020

1 reference

Microglial priming in neurodegenerative disease

31 March 2020

1 reference

Microglia and neurodegeneration: the role of systemic inflammation.

31 March 2020

1 reference

Neuroinflammatory phenotype in early Alzheimer's disease

31 March 2020

1 reference

Deciphering the mechanism underlying late-onset Alzheimer disease

31 March 2020

1 reference

TREM2 and the neuroimmunology of Alzheimer's disease

31 March 2020

1 reference

Innate immune activation in neurodegenerative disease

31 March 2020

1 reference

Inflammation and Alzheimer's disease

31 March 2020

1 reference

A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

31 March 2020

1 reference

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

31 March 2020

1 reference

Animal models of Alzheimer disease

31 March 2020

1 reference

Trafficking and proteolytic processing of APP

31 March 2020

1 reference

Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

31 March 2020

1 reference

Alzheimer disease therapy--moving from amyloid-β to tau.

31 March 2020

1 reference

Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease

31 March 2020

1 reference

Variant of TREM2 Associated with the Risk of Alzheimer's Disease

31 March 2020

1 reference

TREM2 Variants in Alzheimer's Disease

31 March 2020

1 reference

CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology

31 March 2020

1 reference

Intrathecal inflammation precedes development of Alzheimer's disease

31 March 2020

1 reference

Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview

31 March 2020

1 reference

Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice

31 March 2020

1 reference

Contribution of systemic inflammation to chronic neurodegeneration

31 March 2020

1 reference

Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease

31 March 2020

1 reference

Systemic inflammation and disease progression in Alzheimer disease

31 March 2020

1 reference

Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study

31 March 2020

1 reference

Systemic inflammatory cells fight off neurodegenerative disease

31 March 2020

1 reference

Osteoarthritis accelerates and exacerbates Alzheimer's disease pathology in mice.

31 March 2020

1 reference

Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.

31 March 2020

1 reference

Mild cognitive impairment in patients with moderate to severe chronic plaque psoriasis

31 March 2020

1 reference

Obesity is associated with hypothalamic injury in rodents and humans

31 March 2020

1 reference

Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes

31 March 2020

1 reference

Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives

31 March 2020

1 reference

Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice.

31 March 2020

1 reference

Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox

31 March 2020

1 reference

Abeta-induced inflammatory processes in microglia cells of APP23 transgenic mice

31 March 2020

1 reference

Invasion of hematopoietic cells into the brain of amyloid precursor protein transgenic mice.

31 March 2020

1 reference

Neuroinflammation in Alzheimer's disease and prion disease.

31 March 2020

1 reference

Microglia and Alzheimer's disease pathogenesis

31 March 2020

1 reference

Heterogeneity of CNS myeloid cells and their roles in neurodegeneration

31 March 2020

1 reference

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

31 March 2020

1 reference

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

31 March 2020

1 reference

Effect of complement CR1 on brain amyloid burden during aging and its modification by APOE genotype

31 March 2020

1 reference

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

31 March 2020

1 reference

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

31 March 2020

1 reference

Identification of a CD20-, FcepsilonRIbeta-, and HTm4-related gene family: sixteen new MS4A family members expressed in human and mouse

31 March 2020

1 reference

Animal models of multiple sclerosis: the good, the bad and the bottom line

31 March 2020

1 reference

Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes

31 March 2020

1 reference

Long-term Cognitive Impairment and Functional Disability Among Survivors of Severe Sepsis

31 March 2020

1 reference

Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease

31 March 2020

1 reference

Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease

31 March 2020

1 reference

Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils

31 March 2020

1 reference

A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation.

31 March 2020

1 reference

Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor

31 March 2020

1 reference

CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer

31 March 2020

1 reference

CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation

31 March 2020

1 reference

Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism.

31 March 2020

1 reference

The LPS receptor (CD14) links innate immunity with Alzheimer's disease

31 March 2020

1 reference

CD36 mediates the innate host response to beta-amyloid

31 March 2020

1 reference

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

31 March 2020

1 reference

Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease

31 March 2020

1 reference

Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline.

31 March 2020

1 reference

Elevated circulating tumor necrosis factor levels in Alzheimer's disease

31 March 2020

1 reference

Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice

31 March 2020

1 reference

Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation.

31 March 2020

1 reference

Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease

31 March 2020

1 reference

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

31 March 2020

1 reference

The role of microglia in amyloid clearance from the AD brain

31 March 2020

1 reference

Dystrophic microglia in the aging human brain

31 March 2020

1 reference

Microglia in neurodegenerative disease

31 March 2020

1 reference

Functional impairment of microglia coincides with Beta-amyloid deposition in mice with Alzheimer-like pathology

31 March 2020

1 reference

Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice

31 March 2020

1 reference

Microglial beclin 1 regulates retromer trafficking and phagocytosis and is impaired in Alzheimer's disease

31 March 2020

1 reference

Decreased clearance of CNS beta-amyloid in Alzheimer's disease

31 March 2020

1 reference

Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia

31 March 2020

1 reference

Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor.

31 March 2020

1 reference

Soluble Aβ oligomers are rapidly sequestered from brain ISF in vivo and bind GM1 ganglioside on cellular membranes

31 March 2020

1 reference

SnapShot: pathobiology of Alzheimer's disease

31 March 2020

1 reference

Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease

31 March 2020

1 reference

Functions of microglia in the central nervous system--beyond the immune response.

31 March 2020

1 reference

Sublime microglia: expanding roles for the guardians of the CNS.

31 March 2020

1 reference

TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice

31 March 2020

1 reference

The microglial sensome revealed by direct RNA sequencing

31 March 2020

1 reference

A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia

31 March 2020

1 reference

TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis

31 March 2020

1 reference

TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model

31 March 2020

1 reference

TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models.

31 March 2020

1 reference

Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2.

31 March 2020

1 reference

Constitutive repressor activity of CD33 on human monocytes requires sialic acid recognition and phosphoinositide 3-kinase-mediated intracellular signaling

31 March 2020

1 reference

Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta

31 March 2020

1 reference

The effects of aging, injury and disease on microglial function: a case for cellular senescence

31 March 2020

1 reference

Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease

31 March 2020

1 reference

Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy.

31 March 2020

1 reference

Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo

31 March 2020

1 reference

Clearance of amyloid-β peptides by microglia and macrophages: the issue of what, when and where

31 March 2020

1 reference

Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimer's disease.

31 March 2020

1 reference

Differential role of CCR2 in the dynamics of microglia and perivascular macrophages during prion disease

31 March 2020

1 reference

Reactive gliosis and the multicellular response to CNS damage and disease.

31 March 2020

1 reference

Astrocytes: biology and pathology

31 March 2020

1 reference

Astrocytes: conductors of the Alzheimer disease neuroinflammatory symphony

31 March 2020

1 reference

Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice

31 March 2020

1 reference

Age-dependent decrease in glutamine synthetase expression in the hippocampal astroglia of the triple transgenic Alzheimer's disease mouse model: mechanism for deficient glutamatergic transmission?

31 March 2020

1 reference

Targeting astrocytes ameliorates neurologic changes in a mouse model of Alzheimer's disease.

31 March 2020

1 reference

Astrocytes accumulate Aβ42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains

31 March 2020

1 reference

Adult mouse astrocytes degrade amyloid-beta in vitro and in situ

31 March 2020

1 reference

Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides

31 March 2020

1 reference

Critical role of astroglial apolipoprotein E and liver X receptor-α expression for microglial Aβ phagocytosis.

31 March 2020

1 reference

Multiple cellular and molecular mechanisms are involved in human Aβ clearance by transplanted adult astrocytes

31 March 2020

1 reference

Proteolytic degradation of amyloid β-protein

31 March 2020

1 reference

Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature

31 March 2020

1 reference

Focal demyelination in Alzheimer's disease and transgenic mouse models.

31 March 2020

1 reference

Expression of complement messenger RNAs and proteins by human oligodendroglial cells

31 March 2020

1 reference

Complement-activated oligodendroglia: a new pathogenic entity identified by immunostaining with antibodies to human complement proteins C3d and C4d.

31 March 2020

1 reference

Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia

31 March 2020

1 reference

CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models.

31 March 2020

1 reference

An immunofluorescence method for postembedded tissue in the acrylic resin Technovit 9100 New using fluorescein isothiocyanate secondary detection.

31 March 2020

1 reference

Deficiency of complement defense protein CD59 may contribute to neurodegeneration in Alzheimer's disease

31 March 2020

1 reference

Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: a potential mechanism leading to chronic inflammation

31 March 2020

1 reference

Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease

31 March 2020

1 reference

Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway.

31 March 2020

1 reference

Endothelin-1 is elevated in Alzheimer's disease and upregulated by amyloid-β.

31 March 2020

1 reference

Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease

31 March 2020

1 reference

Molecular links between endothelial dysfunction and neurodegeneration in Alzheimer's disease.

31 March 2020

1 reference

Emerging therapeutics for Alzheimer's disease

31 March 2020

1 reference

Characterization of the microglial phenotype under specific pro-inflammatory and anti-inflammatory conditions: Effects of oligomeric and fibrillar amyloid-beta

31 March 2020

1 reference

The M1 and M2 paradigm of macrophage activation: time for reassessment

31 March 2020

1 reference

Mast cells: an expanding pathophysiological role from allergy to other disorders

31 March 2020

1 reference

Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial

31 March 2020

1 reference

Do nonsteroidal antiinflammatory drugs reduce the risk of Alzheimer's disease?

31 March 2020

1 reference

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

31 March 2020

1 reference

The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease

31 March 2020

1 reference

Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib

31 March 2020

1 reference

Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial

31 March 2020

1 reference

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial

31 March 2020

1 reference

Extended results of the Alzheimer's disease anti-inflammatory prevention trial

31 March 2020

1 reference

Parallel discovery of Alzheimer's therapeutics

31 March 2020

1 reference

Peripheral inflammatory cytokines as biomarkers in Alzheimer's disease and mild cognitive impairment

31 March 2020

1 reference

Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease

31 March 2020

1 reference

Interleukin-23 receptor polymorphisms are associated with Alzheimer's disease in Han Chinese.

31 March 2020

1 reference

IL12/23 p40 inhibition ameliorates Alzheimer's disease-associated neuropathology and spatial memory in SAMP8 mice

31 March 2020

1 reference

Neuroinflammatory cytokine signaling and Alzheimer's disease

31 March 2020

1 reference

The NALP3 inflammasome is involved in the innate immune response to amyloid-beta

31 March 2020

1 reference

NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice

31 March 2020

1 reference

A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.

31 March 2020

1 reference

PPARγ/RXRα-induced and CD36-mediated microglial amyloid-β phagocytosis results in cognitive improvement in amyloid precursor protein/presenilin 1 mice.

31 March 2020

1 reference

ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models

31 March 2020

1 reference

Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models".

31 March 2020

1 reference

Comment on "ApoE-Directed Therapeutics Rapidly Clear -Amyloid and Reverse Deficits in AD Mouse Models"

31 March 2020

1 reference

Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models".

31 March 2020

1 reference

Comment on "ApoE-Directed Therapeutics Rapidly Clear -Amyloid and Reverse Deficits in AD Mouse Models"

31 March 2020

1 reference

Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease

31 March 2020

1 reference

Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy.

31 March 2020

1 reference

Scara1 deficiency impairs clearance of soluble amyloid-β by mononuclear phagocytes and accelerates Alzheimer's-like disease progression

31 March 2020

1 reference

Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice

31 March 2020

1 reference

Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease.

31 March 2020

1 reference

Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice

31 March 2020

1 reference

Synaptic pruning by microglia is necessary for normal brain development

31 March 2020

1 reference

Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner

31 March 2020

1 reference

The complement system: an unexpected role in synaptic pruning during development and disease

31 March 2020

1 reference

Transforming growth factor-beta 1 is in plaques in Alzheimer and Down pathologies.

31 March 2020

1 reference

TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice.

31 March 2020

1 reference

Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology

31 March 2020

1 reference

A meta-analysis of cytokines in Alzheimer's disease

31 March 2020

1 reference

Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease

31 March 2020

1 reference

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

31 March 2020

1 reference

A limited role for microglia in antibody mediated plaque clearance in APP mice

31 March 2020

1 reference

Quantitative and mechanistic studies of Abeta immunotherapy

31 March 2020

1 reference

Rapid microglial response around amyloid pathology after systemic anti-Abeta antibody administration in PDAPP mice

31 March 2020

1 reference

Intracranially Administered Anti-Αβ Antibodies Reduce β-Amyloid Deposition by Mechanisms Both Independent of and Associated with Microglial Activation

31 March 2020

1 reference

Microglial activation facilitates Abeta plaque removal following intracranial anti-Abeta antibody administration

31 March 2020

1 reference

Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition.

31 March 2020

1 reference

Robust amyloid clearance in a mouse model of Alzheimer's disease provides novel insights into the mechanism of amyloid-beta immunotherapy

31 March 2020

1 reference

Alzheimer's disease: strategies for disease modification

31 March 2020

1 reference

Aspirin-triggered lipoxin A4 stimulates alternative activation of microglia and reduces Alzheimer disease-like pathology in mice

31 March 2020

1 reference

AAV serotype 2/1-mediated gene delivery of anti-inflammatory interleukin-10 enhances neurogenesis and cognitive function in APP+PS1 mice

31 March 2020

1 reference

IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior.

31 March 2020

1 reference

Hippocampal expression of murine IL-4 results in exacerbation of amyloid deposition

31 March 2020

1 reference

CHF5074, a novel gamma-secretase modulator, attenuates brain beta-amyloid pathology and learning deficit in a mouse model of Alzheimer's disease.

31 March 2020

1 reference

Multi-target action of the novel anti-Alzheimer compound CHF5074: in vivo study of long term treatment in Tg2576 mice.

31 March 2020

1 reference

CHF5074 reduces biomarkers of neuroinflammation in patients with mild cognitive impairment: a 12-week, double-blind, placebo-controlled study.

31 March 2020

1 reference

The ageing systemic milieu negatively regulates neurogenesis and cognitive function.

31 March 2020

1 reference

Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice.

31 March 2020

1 reference

Cellular resistance to infection

31 March 2020

1 reference

Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity

31 March 2020

1 reference

Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation

31 March 2020

1 reference

M-1/M-2 macrophages and the Th1/Th2 paradigm

31 March 2020

1 reference

Transcription factors and CD4 T cells seeking identity: masters, minions, setters and spikers

31 March 2020

1 reference

Helper T-cell differentiation and plasticity: insights from epigenetics.

31 March 2020

1 reference

Regulators of chromatin state and transcription in CD4 T-cell polarization

31 March 2020

1 reference

Transcriptional regulation of macrophage polarization: enabling diversity with identity

31 March 2020

1 reference

Defining GM-CSF- and macrophage-CSF-dependent macrophage responses by in vitro models

31 March 2020

1 reference

Transcriptome-based network analysis reveals a spectrum model of human macrophage activation.

31 March 2020

1 reference

A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model

31 March 2020

1 reference

Neurotoxicity of amyloid β-protein: synaptic and network dysfunction

31 March 2020

1 reference

Up-regulation of FPR2, a chemotactic receptor for amyloid beta 1-42 (A beta 42), in murine microglial cells by TNF alpha

31 March 2020

1 reference

Amyloid beta peptide 1-40 enhances the action of Toll-like receptor-2 and -4 agonists but antagonizes Toll-like receptor-9-induced inflammation in primary mouse microglial cell cultures

31 March 2020

1 reference

CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation.

31 March 2020

1 reference

Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release

31 March 2020

1 reference

A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease.

31 March 2020

1 reference

Massive gliosis induced by interleukin-6 suppresses Abeta deposition in vivo: evidence against inflammation as a driving force for amyloid deposition

31 March 2020

1 reference

Hippocampal expression of murine TNFα results in attenuation of amyloid deposition in vivo

31 March 2020

1 reference

Tumor necrosis factor death receptor signaling cascade is required for amyloid-beta protein-induced neuron death.

31 March 2020

1 reference

Differential activation of tumor necrosis factor receptors distinguishes between brains from Alzheimer's disease and non-demented patients

31 March 2020

1 reference

Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration

31 March 2020

1 reference

Block of purinergic P2X(7) receptor is neuroprotective in an animal model of Alzheimer's disease

31 March 2020

1 reference

In vivo P2X7 inhibition reduces amyloid plaques in Alzheimer's disease through GSK3β and secretases.

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRN3880

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25991443%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

8 March 2020

1005784241

0 references

Fatcat ID

release_aethxgergrdbtgmiemu6luifsq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/aethxgergrdbtgmiemu6luifsq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25991443%20AND%20SRC:MED&resulttype=core&format=json